480 likes | 1.51k Views
Instruments in Nuclear Medicine. Department of Nuclear Medicine Renji Hospital. Principle of Detection of Radiation. Ionization Excitation Chemical mechanism Annihilation radiation. Detector. Ionization detector Scintillation detector. In vitro radioassay.
E N D
Instruments in Nuclear Medicine Department of Nuclear Medicine Renji Hospital
Principle of Detection of Radiation • Ionization • Excitation • Chemical mechanism • Annihilation radiation
Detector • Ionization detector • Scintillation detector
In vitro radioassay • γcounter ( well-type γcounter) • βcounter ( liquid scintillation counter)
Radionuclide Imaging scintillation scanner PET SPECT γ camera
γ Camera γ camera collimator crystal photomultiplier pulse height analyzer electric element
Computed Tomography (CT) Computed Tomography (CT) Single Photon Emission Computed Tomography (SPECT) Emission Computed Tomography (ECT) Positron Emission Tomography (PET) Transmission Computed Tomography (TCT)
Single Photon Emission Computed Tomography (SPECT) Single Photon Emission Computed Tomography • Filtered backprojection, FBP • Quality Control (QC) on SPECT imaging • Field uniformity and correction • Determination and correction of center of rotation • X and Y gain calibration pixels • QC of collimator • etc.
How PET Works • A short-lived radioactivesubstance such as 18F is injected into the bloodstream as glucose The • Radionuclides decay by emitting a positron, which would annihilate with an electron in the tissue to produce gamma rays • Gamma rays fly off in oppositedirections into the detectors. enables the location of the original electron to be pinpointed
Fusion of Images • PET-CT • SPECT-CT • PET-MRI • SPECT-MRI
Fusion of Images Image Fusion with CT
Fusion of Images Image Fusion with MR
Radiopharmaceutical Radiopharmaceuticals have been defined as products labeled with one or several radioactive atoms, which are used for the purpose of diagnosis or therapy Iodine-131, 131I and Xenon-133, 133Xe, etc 99mTc-ECD, 99mTc-HSA, 99mTc-MAA, 99mTc-RBC, etc
Production of Radionuclides • Reactor-produced radionuclide A-1 ZX + n A-1ZX + γ 133Xe, 99Mo, 131I, etc • Cyclotron-produced radionuclide beta-plus decay; electron capture decay 201Tl, 67Ga, 123I, 111In, 18F, 11C, etc • Generator-produced radionuclides 68Ga, 99mTc, 113mIn
Properties of the Ideal Diagnostic Radiopharmaceutical • Type of emission pure gamma-ray emitter, decaying by either electron capture or isomeric transition • Energy 100kev~250kev • Availability • Target-to-nontarget ratio • Effective half life
Properties of the Ideal Therapeutic Radiopharmaceutical • Type of emission pure beta-minus emission • Energy (β emitter >1MeV) • Target-to-nontarget ratio • Effective half life
Positron Radiopharmaceutical • Positron nuclides 11C, 13N, 15O, 18F, 62Cu, 68Cu, 82Rb, 75Br, 38K, 73Se, 94mTc • Positron Radiopharmaceutical 18FDG, 6- [18F]-L-DOPA, 11C-DOPA, 18F-MET, 11C-Tyr, 18F-FLT, etc
QA of Radiopharmaceutical • Radionuclide purity • Radiochemical purity • Chemical purity • Sterility • Apyrogenicity • Absence of foreign particulate matter • Particle size (if appropriate) • pH • Biological distribution
Review • What is radiopharmaceutical? • What is SPECT? • What is PET? How it works?
Review • What properties should ideal diagnostic and therapeutic radiopharmaceutical have? • Where are radionuclides producted from? • What aspects does QA involve using radiopharmaceutical?